{"title":"Aphonia.","authors":"C. Mccaskey","doi":"10.32388/aq9gne","DOIUrl":"https://doi.org/10.32388/aq9gne","url":null,"abstract":"","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82619933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2005-01-01DOI: 10.1001/archderm.1981.01650070068032
Gurcharan Singh, L. Kumar
The exact etiology still remains controversial and this is partly due to the variability in the clinical situations in which striae arise. They are the end result of various physiologic states, including pregnancy, adrenocortical excess and changes in body habitus, as seen in rapid weight change. A genetic predisposition is presumed; striae distensae have been reported in monozygotic twins. There is decreased expression of collagen and fibronectin genes in affected tissue. The role of genetic factors is further emphasized by the fact that they are common in inherited defects of connective tissue, as in Marfan’s syndrome.
{"title":"Resident's page.","authors":"Gurcharan Singh, L. Kumar","doi":"10.1001/archderm.1981.01650070068032","DOIUrl":"https://doi.org/10.1001/archderm.1981.01650070068032","url":null,"abstract":"The exact etiology still remains controversial and this is partly due to the variability in the clinical situations in which striae arise. They are the end result of various physiologic states, including pregnancy, adrenocortical excess and changes in body habitus, as seen in rapid weight change. A genetic predisposition is presumed; striae distensae have been reported in monozygotic twins. There is decreased expression of collagen and fibronectin genes in affected tissue. The role of genetic factors is further emphasized by the fact that they are common in inherited defects of connective tissue, as in Marfan’s syndrome.","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74250942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1991-02-01DOI: 10.1097/00000478-199102000-00013
E. Foucar, J. Rosai, R. Dorfman
Sinus histiocytosis with massive lymphadenopathy (SHML) is a newly recognized, distinct, pseudolymphomatous benign entity with very characteristic microscopic features. Most patients are children or young adults with massive painless cervical adenopathy, although other node groups and extranodal sites often are involved. Sixteen patients with SHML involving the upper respiratory tract and/ or salivary gland are presented. Nine of the patients had ear, nose, and throat (ENT) manifestations at the time of presentation. In most cases the ENT involvement resulted in prominent clinical symptoms. Treatment included surgery, antibiotics, irradiation, chemotherapy, and steroids, frequently in combination, but no consistent pattern of response emerged from the study. These 16 patients were very similar clinically to patients with SHML who did not have ENT disease, indicating that extranodal involvement is not associated with more aggressive disease.
{"title":"Sinus histiocytosis with massive lymphadenopathy.","authors":"E. Foucar, J. Rosai, R. Dorfman","doi":"10.1097/00000478-199102000-00013","DOIUrl":"https://doi.org/10.1097/00000478-199102000-00013","url":null,"abstract":"Sinus histiocytosis with massive lymphadenopathy (SHML) is a newly recognized, distinct, pseudolymphomatous benign entity with very characteristic microscopic features. Most patients are children or young adults with massive painless cervical adenopathy, although other node groups and extranodal sites often are involved. Sixteen patients with SHML involving the upper respiratory tract and/ or salivary gland are presented. Nine of the patients had ear, nose, and throat (ENT) manifestations at the time of presentation. In most cases the ENT involvement resulted in prominent clinical symptoms. Treatment included surgery, antibiotics, irradiation, chemotherapy, and steroids, frequently in combination, but no consistent pattern of response emerged from the study. These 16 patients were very similar clinically to patients with SHML who did not have ENT disease, indicating that extranodal involvement is not associated with more aggressive disease.","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1991-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80517872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-12-01DOI: 10.1001/ARCHOTOL.1985.00800140071017
B. Vikram, E. Strong, J. Shah, R. Spiro
To the Editor .—DeSanto et al 1 have twice misquoted us. On page 369, they cite one of our articles 2 as suggesting that "A new and realistic concern is that the effects of radiation on lymphatics may actually facilitate distant metastases and decrease survivorship rather than improve it." In actual fact, rather than raising such concerns, our data are really reassuring in this regard; we found that the overall incidence of distant metastases in patients treated by the combination of surgery and postoperative radiation therapy was remarkably similar to what had been previously observed at our institution in patients treated by surgery alone. 3 On page 370, DeSanto et al again cite us, suggesting that "control of the disease (by postoperative radiation therapy) did not lead to increased survivorship." In actual fact, our data do show a rather striking decrease in deaths from head and neck cancer in patients treated by surgery
{"title":"Irradiation after neck dissection.","authors":"B. Vikram, E. Strong, J. Shah, R. Spiro","doi":"10.1001/ARCHOTOL.1985.00800140071017","DOIUrl":"https://doi.org/10.1001/ARCHOTOL.1985.00800140071017","url":null,"abstract":"To the Editor .—DeSanto et al 1 have twice misquoted us. On page 369, they cite one of our articles 2 as suggesting that \"A new and realistic concern is that the effects of radiation on lymphatics may actually facilitate distant metastases and decrease survivorship rather than improve it.\" In actual fact, rather than raising such concerns, our data are really reassuring in this regard; we found that the overall incidence of distant metastases in patients treated by the combination of surgery and postoperative radiation therapy was remarkably similar to what had been previously observed at our institution in patients treated by surgery alone. 3 On page 370, DeSanto et al again cite us, suggesting that \"control of the disease (by postoperative radiation therapy) did not lead to increased survivorship.\" In actual fact, our data do show a rather striking decrease in deaths from head and neck cancer in patients treated by surgery","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1985-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91262528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-05-01DOI: 10.1001/archotol.1985.00800070035001
R. Sweetow
{"title":"Counseling the patient with tinnitus.","authors":"R. Sweetow","doi":"10.1001/archotol.1985.00800070035001","DOIUrl":"https://doi.org/10.1001/archotol.1985.00800070035001","url":null,"abstract":"","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1985-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82944175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-04-01DOI: 10.1001/ARCHOTOL.1985.00800060104021
R. Roy, D. B. Weeks
To the Editor .—In a recent commentary, Brummett 1 drew attention to a common, yet potentially life-threatening, drug interaction between nonselective β-adrenergic blockers and epinephrine. However, there were some serious typographical errors in his article and misleading recommendations as to the appropriate clinical response. First, β 1 and β 2 have been transposed throughout the commentary. The β 1 -receptors, not the β 2 , are those found in the heart, which, when stimulated, increase heart rate and contractility. 2 Epinephrine activates both α- and β 2 -receptors in blood vessels to mediate the opposing effects of vasoconstriction (α) and vasodilation (β 2 ). The net effect of low doses of epinephrine in healthy patients is only an increase in heart rate because of β 1 stimulation. 3 Higher doses of epinephrine produce systolic hypertension as well as tachycardia. 3 If the β 1 - and β 2 -receptors are blocked by a
{"title":"Otolaryngologists using local anesthetics containing epinephrine.","authors":"R. Roy, D. B. Weeks","doi":"10.1001/ARCHOTOL.1985.00800060104021","DOIUrl":"https://doi.org/10.1001/ARCHOTOL.1985.00800060104021","url":null,"abstract":"To the Editor .—In a recent commentary, Brummett 1 drew attention to a common, yet potentially life-threatening, drug interaction between nonselective β-adrenergic blockers and epinephrine. However, there were some serious typographical errors in his article and misleading recommendations as to the appropriate clinical response. First, β 1 and β 2 have been transposed throughout the commentary. The β 1 -receptors, not the β 2 , are those found in the heart, which, when stimulated, increase heart rate and contractility. 2 Epinephrine activates both α- and β 2 -receptors in blood vessels to mediate the opposing effects of vasoconstriction (α) and vasodilation (β 2 ). The net effect of low doses of epinephrine in healthy patients is only an increase in heart rate because of β 1 stimulation. 3 Higher doses of epinephrine produce systolic hypertension as well as tachycardia. 3 If the β 1 - and β 2 -receptors are blocked by a","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1985-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84507505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-02-01DOI: 10.1097/00006534-198606000-00049
D. Ophir, A. Shapira, G. Marshak
A variety of surgical procedures are performed to open the nasal airway chronically obstructed by hypertrophic inferior turbinates. Because the results are universally unsatisfactory, we suggest bilateral total inferior turbinectomy to patients in whom medical therapy fails. One hundred fifty patients were followed up for one to seven years (mean, 2 1/2 years) and the results of the follow-up were assessed clinically via questionnaire and chart review. Patent nasal airway resulted in 91% of the patients. Eighty percent of the patients reported improvement in nasal breathing, and 14 (27%) of the 51 patients who suffered from nasal drainage preoperatively reported that it had stopped after the operation. Of the 39 patients who had anosmia preoperatively, 46% reported the restoration of their sense of smell. Postoperative complications are minimal, and no patient complained of crusts, dryness, or foul odor.
{"title":"Total inferior turbinectomy for nasal airway obstruction.","authors":"D. Ophir, A. Shapira, G. Marshak","doi":"10.1097/00006534-198606000-00049","DOIUrl":"https://doi.org/10.1097/00006534-198606000-00049","url":null,"abstract":"A variety of surgical procedures are performed to open the nasal airway chronically obstructed by hypertrophic inferior turbinates. Because the results are universally unsatisfactory, we suggest bilateral total inferior turbinectomy to patients in whom medical therapy fails. One hundred fifty patients were followed up for one to seven years (mean, 2 1/2 years) and the results of the follow-up were assessed clinically via questionnaire and chart review. Patent nasal airway resulted in 91% of the patients. Eighty percent of the patients reported improvement in nasal breathing, and 14 (27%) of the 51 patients who suffered from nasal drainage preoperatively reported that it had stopped after the operation. Of the 39 patients who had anosmia preoperatively, 46% reported the restoration of their sense of smell. Postoperative complications are minimal, and no patient complained of crusts, dryness, or foul odor.","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1985-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82871467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-01-01DOI: 10.1001/archotol.1985.00800080102017
{"title":"Ventilating tubes.","authors":"","doi":"10.1001/archotol.1985.00800080102017","DOIUrl":"https://doi.org/10.1001/archotol.1985.00800080102017","url":null,"abstract":"","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74644901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1984-12-01DOI: 10.1001/ARCHOTOL.1984.00800380015005
J. Gavilán, C. Gavilán
Middle fossa vestibular neurectomy is especially useful for treatment of Meniere's disease. We treated 59 cases of Meniere's disease with this technique and followed them up for at least ten years. Middle fossa vestibular neurectomy was effective against vertigo in Meniere's disease in 100% of the cases with unilateral involvement. Hearing, as well as tinnitus and hyperacusis, showed a clearly favorable evolution after vestibular neurectomy. The excellent long-term effects of this procedure on vertigo and low incidence of complications make middle fossa vestibular neurectomy one of the most effective surgical treatments for Meniere's disease.
{"title":"Middle fossa vestibular neurectomy. Long-term results.","authors":"J. Gavilán, C. Gavilán","doi":"10.1001/ARCHOTOL.1984.00800380015005","DOIUrl":"https://doi.org/10.1001/ARCHOTOL.1984.00800380015005","url":null,"abstract":"Middle fossa vestibular neurectomy is especially useful for treatment of Meniere's disease. We treated 59 cases of Meniere's disease with this technique and followed them up for at least ten years. Middle fossa vestibular neurectomy was effective against vertigo in Meniere's disease in 100% of the cases with unilateral involvement. Hearing, as well as tinnitus and hyperacusis, showed a clearly favorable evolution after vestibular neurectomy. The excellent long-term effects of this procedure on vertigo and low incidence of complications make middle fossa vestibular neurectomy one of the most effective surgical treatments for Meniere's disease.","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1984-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83615096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1984-10-01DOI: 10.1097/00006534-198608000-00045
R. Webster, M. D. Kattner, R. C. Smith
We treated 87 patients with injectable collagen during a period of 2 1/2 years. Intradermal augmentations were found to be particularly valuable in frown grooves, the groove between the cheek and the lips and chin, the groove beneath the malar prominence, and the groove just lateral to the labial commissure, and for enhancement of malar pads or prominences. Less successfully treated were fine lines, postrhinoplastic depressions, and punched-out, depressed scars. The augmentations are less permanent, more painful, and more costly than those provided by subdermal injections of silicone, but injectable collagen is available generally for these purposes and injectable silicone is not. Problems of allergy also are drawbacks to the use of injectable collagen. Even with its disadvantages, however, injectable collagen is presently valuable in total care of aging faces and certain scarring.
{"title":"Injectable collagen for augmentation of facial areas.","authors":"R. Webster, M. D. Kattner, R. C. Smith","doi":"10.1097/00006534-198608000-00045","DOIUrl":"https://doi.org/10.1097/00006534-198608000-00045","url":null,"abstract":"We treated 87 patients with injectable collagen during a period of 2 1/2 years. Intradermal augmentations were found to be particularly valuable in frown grooves, the groove between the cheek and the lips and chin, the groove beneath the malar prominence, and the groove just lateral to the labial commissure, and for enhancement of malar pads or prominences. Less successfully treated were fine lines, postrhinoplastic depressions, and punched-out, depressed scars. The augmentations are less permanent, more painful, and more costly than those provided by subdermal injections of silicone, but injectable collagen is available generally for these purposes and injectable silicone is not. Problems of allergy also are drawbacks to the use of injectable collagen. Even with its disadvantages, however, injectable collagen is presently valuable in total care of aging faces and certain scarring.","PeriodicalId":8315,"journal":{"name":"Archives of otolaryngology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1984-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84021914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：